Inhibition of TGF-β expression: A novel role for thiazolidinediones to implement renoprotection in diabetes

Research output: Contribution to journalArticle

Abstract

Actual strategies to delay progression of diabetic nephropathy provide imperfect protection when started late in the course of the disease. Ohtomo et al. now demonstrate that thiazolidinedione treatment was associated with a remarkable improvement in proteinuria and renal function, offering a new potential treatment for diabetic nephropathy.

Original languageEnglish
Pages (from-to)1419-1421
Number of pages3
JournalKidney International
Volume72
Issue number12
DOIs
Publication statusPublished - Dec 2007

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Inhibition of TGF-β expression: A novel role for thiazolidinediones to implement renoprotection in diabetes'. Together they form a unique fingerprint.

  • Cite this